glp 1 conference GLP-1 pills, immunology, and China, oh my: JPM 2026 Obesity Management Gold Standard

A simple dose adjustment is often all it takes to resolve the issue

Semaglutide GLP-1 / GLP-1 2Multiple Endocrine Neoplasia syndrome type 2, MEN 2 **

With an increasing burden of diabetes and obesity, these drugs have the potential to reshape public health policies, redefine preventive care, and alter the economic landscape of the pharmaceutical industry

Thus, any treatment capable of augmenting glucose metabolism in -cells may result in clinical benefit from improvement in insulin secretion and overall glucose homeostasis

What you decide next is entirely up to you

16 Based on these data, it is reasonable to decrease background prandial insulin doses by 50%, or even hold the prandial insulin altogether in patients with good glucose control or a history of hypoglycemia when starting a GLP-1 RA